NM_001374736.1:c.4845G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001374736.1(DST):c.4845G>A(p.Arg1615Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0129 in 1,611,390 control chromosomes in the GnomAD database, including 173 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 11 hom., cov: 32)
Exomes 𝑓: 0.013 ( 162 hom. )
Consequence
DST
NM_001374736.1 synonymous
NM_001374736.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.290
Publications
2 publications found
Genes affected
DST (HGNC:1090): (dystonin) This gene encodes a member of the plakin protein family of adhesion junction plaque proteins. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the full-length nature of some variants has not been defined. It has been reported that some isoforms are expressed in neural and muscle tissue, anchoring neural intermediate filaments to the actin cytoskeleton, and some isoforms are expressed in epithelial tissue, anchoring keratin-containing intermediate filaments to hemidesmosomes. Consistent with the expression, mice defective for this gene show skin blistering and neurodegeneration. [provided by RefSeq, Mar 2010]
DST Gene-Disease associations (from GenCC):
- hereditary sensory and autonomic neuropathy type 6Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.043).
BP6
Variant 6-56624614-C-T is Benign according to our data. Variant chr6-56624614-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474518.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0104 (1574/152050) while in subpopulation NFE AF = 0.016 (1088/67960). AF 95% confidence interval is 0.0152. There are 11 homozygotes in GnomAd4. There are 728 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DST | ENST00000680361.1 | c.4845G>A | p.Arg1615Arg | synonymous_variant | Exon 36 of 104 | NM_001374736.1 | ENSP00000505098.1 | |||
| DST | ENST00000370765.11 | c.3234G>A | p.Arg1078Arg | synonymous_variant | Exon 22 of 24 | 1 | NM_001723.7 | ENSP00000359801.6 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1574AN: 151932Hom.: 11 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1574
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0103 AC: 2583AN: 250688 AF XY: 0.0102 show subpopulations
GnomAD2 exomes
AF:
AC:
2583
AN:
250688
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0131 AC: 19146AN: 1459340Hom.: 162 Cov.: 30 AF XY: 0.0127 AC XY: 9235AN XY: 726166 show subpopulations
GnomAD4 exome
AF:
AC:
19146
AN:
1459340
Hom.:
Cov.:
30
AF XY:
AC XY:
9235
AN XY:
726166
show subpopulations
African (AFR)
AF:
AC:
78
AN:
33428
American (AMR)
AF:
AC:
423
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
582
AN:
26108
East Asian (EAS)
AF:
AC:
2
AN:
39666
South Asian (SAS)
AF:
AC:
179
AN:
86202
European-Finnish (FIN)
AF:
AC:
133
AN:
53168
Middle Eastern (MID)
AF:
AC:
27
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
16950
AN:
1109984
Other (OTH)
AF:
AC:
772
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
855
1710
2564
3419
4274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0104 AC: 1574AN: 152050Hom.: 11 Cov.: 32 AF XY: 0.00979 AC XY: 728AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
1574
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
728
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
110
AN:
41510
American (AMR)
AF:
AC:
175
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
87
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
10
AN:
4810
European-Finnish (FIN)
AF:
AC:
18
AN:
10576
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1088
AN:
67960
Other (OTH)
AF:
AC:
24
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
80
160
240
320
400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.